Status:

COMPLETED

Effect of Irvingia Gabonensis (Bush Mango)on Parameters Associated With Metabolic Syndrome

Lead Sponsor:

Gateway Health Alliance

Collaborating Sponsors:

University of Yaounde

Conditions:

Metabolic Syndrome

Obesity

Eligibility:

All Genders

19-50 years

Phase:

NA

Brief Summary

The study investigated the use and efficacy of the seeds of African bush mango (Irvingia gabonensis)to control body weight, blood lipids and hormones in overweight and obese people.

Detailed Description

To assess the effects of seeds of Irvingia gabonensis on body weight, fasting blood glucose, plasma total and LDL cholesterol in 102 overweight and obese participants. The study was a 10 week randomi...

Eligibility Criteria

Inclusion

  • BMI\>26

Exclusion

  • Diabetics Pregnant and lactating Participating in any other weight reducing program Smokers

Key Trial Info

Start Date :

November 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2007

Estimated Enrollment :

102 Patients enrolled

Trial Details

Trial ID

NCT00645775

Start Date

November 1 2006

End Date

April 1 2007

Last Update

March 28 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Laboratory of Nutrition & Nutritional Biochemistry

Yaoundé, Centre Region, Cameroon, BP812

Effect of Irvingia Gabonensis (Bush Mango)on Parameters Associated With Metabolic Syndrome | DecenTrialz